Octreotide infusion pump in patients with functional neuroendocrine tumors and refractory hormonal syndrome
{{output}}
Objective: To evaluate clinical outcomes, safety and survival measures of octreotide infusion pump (OIP) therapy in patients with metastatic neuroendocrine tumors (NETs) and refractory hormonal syndrome. ... ...
